Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5M Buy
189,869
+49,122
+35% +$6.36M 2.75% 9
2026
Q1
$18M Buy
140,747
+10,348
+8% +$1.56M 2.21% 17
2025
Q4
$19.6M Sell
130,399
-1,672
-1% -$236K 2.47% 14
2025
Q3
$18.5M Sell
132,071
-1,790
-1% -$245K 2.44% 13
2025
Q2
$16.1M Sell
133,861
-62,220
-32% -$6.95M 2.47% 10
2025
Q1
$24M Buy
196,081
+9,541
+5% +$1.21M 4.22% 2
2024
Q4
$23.7M Buy
186,540
+89,900
+93% +$10.4M 3.94% 2
2024
Q3
$9.52M Buy
96,640
+8,345
+9% +$770K 1.69% 22
2024
Q2
$8.39M Buy
88,295
+5,185
+6% +$489K 1.58% 22
2024
Q1
$8.72M Buy
83,110
+63,250
+318% +$6.3M 1.73% 23
2023
Q4
$1.98M Sell
19,860
-15,040
-43% -$1.56M 0.3% 84
2023
Q3
$3.67M Buy
+34,900
New +$3.91M 0.51% 46

Other funds holding JBTM

Advisory Research's JBTM Position: Q2 2026 in Review

Advisory Research increased its JBT Marel (JBTM) stake by 35% in Q2 2026, buying an estimated $6.36M and bringing the position to 189,869 shares worth $27.5M. The position accounts for 2.75% of the portfolio, ranked #9.

Advisory Research first reported a position in JBTM in Q3 2023 and has held it in 12 quarters since. 392 funds tracked by Wall St. Rank hold JBTM as of Q2 2026.

  • Advisory Research held 189,869 shares of JBT Marel worth $27.5M as of Q2 2026.
  • Advisory Research bought 49,122 JBT Marel shares in Q2 2026, an estimated $6.36M.
  • JBT Marel made up 2.75% of Advisory Research's portfolio in Q2 2026, its #9 holding.
  • Advisory Research first reported a position in JBT Marel in Q3 2023 and has held it in 12 quarters since.
  • 392 funds tracked by Wall St. Rank held JBT Marel as of Q2 2026.

Based on Advisory Research's 13F filing for Q2 2026, filed 13 Aug 2026.